ALWIS Group proudly participated in this high-impact summit focused on advancing drug safety through innovation and collaboration. The two-day event brought together global pharmacovigilance leaders, regulatory experts, and tech pioneers to discuss the evolving landscape of safety monitoring.

At the heart of our presence was ReTrans Enterprise, our flagship AI-powered literature surveillance platform, which continues to gain recognition for its scalability and performance — now live with a Fortune 500 pharmaceutical client.

Highlights from the Event:

• Showcased the power of ReTrans, ZiNex, and ZiQuel in real-world PV operations

• Engaged with industry stakeholders on AI adoption in pharmacovigilance

• Presented insights on improving compliance, automation, and data-driven safety decisions

• Strengthened our global network of drug safety professionals and partners

ALWIS Group remains committed to pushing the boundaries of pharmacovigilance through smart, secure, and scalable technology.